T. Rowe Price Health Sciences Fund I Class
Not enough financial coverage to compute a composite score for THISX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.troweprice.com/financial-intermediary/us/en/investments/mutual-funds/us-products/health-sciences-fund/i-class.html
The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
- IPO
- 2016
- HQ
- Baltimore, MD, US
Price Chart
Valuation
- Market Cap
- $10.92B
- Div Yield
- 12.71%
Performance & Tape
- 52W High
- $96.05
- 52W Low
- $73.75
- 50D MA
- $79.34
- 200D MA
- $83.08
- Beta
- 0.66
- Avg Volume
- 0
Get TickerSpark's AI analysis on THISX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our THISX Coverage
We haven't published any research on THISX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate THISX Report →